A recent study by University Hospitals of Leicester NHS Trust, published in the British Journal of Pharmacology (BJCP), found DoseMeRx (a bed-side Bayesian dosing software) increased the number of vancomycin patients achieving two clinically important targets - Area Under the Curve (AUC24) and Time...
Read more
Wondering how to implement the new 2020 vancomycin dosing guidelines? DoseMeRx is here to help! Watch this four part webinar recording as one of the primary guidelines authors, Dr. Tom Lodise and Cedars-Sinai Medical Center AMS Coordinator, Dr. Ethan Smith guide you through...
Read more
Vancomycin is an antibiotic originally isolated from the bacteria Streptococcus orientalis. It was discovered in the 1950's but became a preferred treatment against infections resistant to other antibiotics, particularly penicillin-resistant staphylococcal infections. Vancomycin is a tricyclic glycopeptide antibiotic that prevents synthesis of peptidoglycan, the main...
Read more
Vancomycin is an antibiotic originally isolated from the bacteria Streptococcus orientalis. It was discovered in the 1950's but it gained popularity in the 1970's for treating antibiotic-resistant infections, particularly penicillin-resistant staphylococcal infections. Vancomycin is a glycopeptide antibiotic that stops bacteria from making peptidoglycan, the main component...
Read moreHIPAA Privacy Statement | Privacy policy | DoseMe & the GDPR | Copyright © 2012 - 2020 DoseMe Pty Ltd. All Rights Reserved.
DoseMe® is a registered trademark of DoseMe Pty Ltd. DoseMeRx℠ and DoseMe℞℠ are service marks of DoseMe LLC.